To investigate the role of IL-33 in glioma progression, immunohistochemistry and reverse transcription polymerase chain reaction (RT-PCR) were performed on normal human brain tissues (n = 6) and glioblastoma multiforme (GBM) specimens (n = 18). This evidence concerns the gene IL33 and central nervous system cancer.